GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (TSX:BCT) » Definitions » E10

BriaCell Therapeutics (TSX:BCT) E10 : C$-27.59 (As of Jan. 2024)


View and export this data going back to 2006. Start your Free Trial

What is BriaCell Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BriaCell Therapeutics's adjusted earnings per share data for the three months ended in Jan. 2024 was C$-0.953. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-27.59 for the trailing ten years ended in Jan. 2024.

During the past 3 years, the average E10 Growth Rate was 4.00% per year. During the past 5 years, the average E10 Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BriaCell Therapeutics was 12.00% per year. The lowest was 4.00% per year. And the median was 9.70% per year.

As of today (2024-05-28), BriaCell Therapeutics's current stock price is C$1.94. BriaCell Therapeutics's E10 for the quarter that ended in Jan. 2024 was C$-27.59. BriaCell Therapeutics's Shiller PE Ratio of today is .


BriaCell Therapeutics E10 Historical Data

The historical data trend for BriaCell Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics E10 Chart

BriaCell Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.26 -31.57 -28.24 -27.43 -27.93

BriaCell Therapeutics Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.34 -27.58 -27.93 -27.74 -27.59

Competitive Comparison of BriaCell Therapeutics's E10

For the Biotechnology subindustry, BriaCell Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BriaCell Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Shiller PE Ratio falls into.



BriaCell Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BriaCell Therapeutics's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.953/125.0724*125.0724
=-0.953

Current CPI (Jan. 2024) = 125.0724.

BriaCell Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201404 -9.783 98.920 -12.369
201407 -134.425 99.315 -169.288
201410 -0.346 99.473 -0.435
201501 -11.427 98.209 -14.553
201504 -3.078 99.710 -3.861
201507 -1.994 100.579 -2.480
201510 -3.000 100.500 -3.733
201601 -3.050 100.184 -3.808
201604 -3.063 101.370 -3.779
201607 -2.634 101.844 -3.235
201610 -2.963 102.002 -3.633
201701 -3.018 102.318 -3.689
201704 -5.909 103.029 -7.173
201707 -11.955 103.029 -14.513
201710 -2.948 103.424 -3.565
201801 -3.023 104.056 -3.634
201804 -2.974 105.320 -3.532
201807 9.163 106.110 10.800
201810 -1.914 105.952 -2.259
201901 -2.947 105.557 -3.492
201904 -2.580 107.453 -3.003
201907 -3.461 108.243 -3.999
201910 -2.414 107.927 -2.797
202001 -2.585 108.085 -2.991
202004 -0.982 107.216 -1.146
202007 -1.800 108.401 -2.077
202010 -0.714 108.638 -0.822
202101 -0.382 109.192 -0.438
202104 0.787 110.851 0.888
202107 -1.322 112.431 -1.471
202110 -2.251 113.695 -2.476
202201 0.896 114.801 0.976
202204 -0.821 118.357 -0.868
202207 -0.039 120.964 -0.040
202210 -0.096 121.517 -0.099
202301 -1.033 121.596 -1.063
202304 -0.431 123.571 -0.436
202307 -0.198 124.914 -0.198
202310 -0.686 125.310 -0.685
202401 -0.953 125.072 -0.953

Add all the adjusted EPS together and divide 10 will get our e10.


BriaCell Therapeutics  (TSX:BCT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BriaCell Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BriaCell Therapeutics (TSX:BCT) Business Description

Traded in Other Exchanges
Address
235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Executives
Jamieson Bondarenko Director

BriaCell Therapeutics (TSX:BCT) Headlines

No Headlines